SAN ANTONIO, TEXAS -- (Marketwired) -- 07/09/13

Bio-Solutions Corporation (OTCQB:BISU)(PINKSHEETS:BISU) is pleased to comment on the unusual trading activity in the company's common stock listed on the OTC market in the United States. Yesterday, the company did receive several calls from shareholders who were concerned about the spike in volume and the slide in price of our shares. We are happy to report that the company and insiders are not sellers of stock at these prices. Furthermore, there are no plans for the company to raise money at these levels. It is reasonable to assume that some shareholders who bought stock under $0.01 might be sellers at these prices.

"The recent roll out of our flagship product is a milestone for the company and we expect to move quickly towards a second production run. Our team is working on finalizing the details of our endorsement deal with Jay Cutler and furthermore we anticipate closing similar deals with top athletes in other professional sports. Our group has outlined a broad media strategy that will kick off once we close our initial deal with Jay Cutler," said Bill Gallagher, president and CEO at Bio-Solutions Corp.

Management is committed to maximizing the long term branding potential for Type 2 Defense and we fully expect that we will be successful in creating sustained value for shareholders on both a short and long term basis. Shareholders can expect prolonged news flow from the company in a timely fashion.

Consumers can find more information about the product by going to www.BioSolutionsCorp.com/product.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes", "expects", "anticipates", "foresees", "forecasts", "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.

Contacts:
Bio-Solutions Corp.
William Gallagher
Chief Executive Officer
210-373-8104

Bio-Solutions Corp.
Josh Williams
Endorsement Deal Coordinator
312-636-1471
joshwilliams0626@yahoo.com
www.BioSolutionsCorp.com